Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus.

Luján MÁ, Castro-Zavala A, Alegre-Zurano L, Valverde O.

Neuropharmacology. 2018 Dec;143:163-175. doi: 10.1016/j.neuropharm.2018.09.043. Epub 2018 Sep 28.

PMID:
30273593
2.

Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.

Greenwald MK.

Neurobiol Stress. 2018 Aug 11;9:84-104. doi: 10.1016/j.ynstr.2018.08.003. eCollection 2018 Nov. Review.

3.

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.

Gonzalez-Cuevas G, Martin-Fardon R, Kerr TM, Stouffer DG, Parsons LH, Hammell DC, Banks SL, Stinchcomb AL, Weiss F.

Neuropsychopharmacology. 2018 Sep;43(10):2036-2045. doi: 10.1038/s41386-018-0050-8. Epub 2018 Mar 22.

4.

Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.

Arellano AL, Papaseit E, Romaguera A, Torrens M, Farré M.

CNS Neurol Disord Drug Targets. 2017;16(5):554-566. doi: 10.2174/1871527316666170413104516. Review.

PMID:
28412920
5.

Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis.

Socías ME, Kerr T, Wood E, Dong H, Lake S, Hayashi K, DeBeck K, Jutras-Aswad D, Montaner J, Milloy MJ.

Addict Behav. 2017 Sep;72:138-143. doi: 10.1016/j.addbeh.2017.04.006. Epub 2017 Apr 4.

6.

Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats.

Mahmud A, Gallant S, Sedki F, D'Cunha T, Shalev U.

J Psychopharmacol. 2017 Jan;31(1):96-104. doi: 10.1177/0269881116667706. Epub 2016 Sep 26.

PMID:
27624146
7.

Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats.

de Carvalho CR, Takahashi RN.

Addict Biol. 2017 May;22(3):742-751. doi: 10.1111/adb.12366. Epub 2016 Feb 1.

PMID:
26833888
8.

Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use.

Fischer B, Kuganesan S, Gallassi A, Malcher-Lopes R, van den Brink W, Wood E.

Int J Drug Policy. 2015 Dec;26(12):1177-82. doi: 10.1016/j.drugpo.2015.09.005. Epub 2015 Sep 25.

PMID:
26500166
9.

Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence.

Prud'homme M, Cata R, Jutras-Aswad D.

Subst Abuse. 2015 May 21;9:33-8. doi: 10.4137/SART.S25081. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center